Clinical Trial

The iLet Experience Study

Recruiting
View on ClinicalTrials.gov →
Summary
A one-year, prospective single-arm cohort study to collect safety and effectiveness data on the iLet Dosing Decision Software during real-world use in people 6 years of age or older with type 1 diabetes (T1D) with 12 months follow-up.
Trial Details
NCT Number NCT06891898
Lead Sponsor Beta Bionics, Inc.
Collaborators: The Scripps Research Institute
Conditions Type 1 Diabetes
Enrollment 1,875 participants
Start Date 2024-05-01
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2025-03-24